The conference will cover the technical and economic aspects specific to generics it answer your questions about industrial constraints, specific regulations, biosimilars, intellectual property with the support of specialists for each of these subjects and the participation of the authorities.
What influence can generics bare on the whole industry?
Are we facing an unprecedented transformation of the pharmaceutical industry?
How are these processes set up in laboratories, among subcontractors, suppliers, distributors? What lessons and perspectives can we drawn?
Whether you are involved with Regulatory Affairs, Production, Quality, Procurement, Analytics, Sales, Development, Strategy / Market... the conference will provide you with visions and perspectives on specific systems and industrial operations.